RALOXIFENE TEVA 60 mg, film-coated tablet 84 tablets
Active ingredients: Raloxifene hydrochloride, Raloxifene
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet84 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RALOXIFENE TEVA 60 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium PVC PVDC de 84 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Prévention et traitement de l'ostéoporose postménopausique du rachis, pour réduire le risque de fractures vertébrales, chez les femmes âgées de moins de 70 ans, sans facteur de risque veineux et avec apport de calcium<br> ; JOURNAL OFFICIEL ; 17/05/01
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Mar 2011
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67050747CIP74933510CIP133400949335107Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE RALOXIFÈNEcomprimé | 60 mg · un comprimé | SA |
| RALOXIFÈNE BASEcomprimé | 56 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.